Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
EMA Considers Cracking Down On Late Filings From Companies By Auto-Releasing Rapporteurs
Oct 31 2024
•
By
Vibha Sharma
EMA is looking at ways to deal with the disruptive impact of delayed marketing submissions
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from EMA
More from Pathways & Standards